...
首页> 外文期刊>Artificial cells, nanomedicine, and biotechnology. >Long non-coding RNA LINC00858 promotes cells proliferation, migration and invasion by acting as a ceRNA of miR-22-3p in colorectal cancer
【24h】

Long non-coding RNA LINC00858 promotes cells proliferation, migration and invasion by acting as a ceRNA of miR-22-3p in colorectal cancer

机译:长非编码RNA LINC00858通过充当miR-22-3p在大肠癌中的ceRNA来促进细胞增殖,迁移和侵袭

获取原文

摘要

Though long non-coding RNA LINC00858 (LINC00858) has been shown to be involved in tumours of other tissues, its involvement in colorectal cancer (CRC) is still unknown. We aimed to investigated expression and mechanism LINC00858 in human CRC. In this study, we firstly found that LINC00858 expression was significantly up-regulated in both CRC tissues and cell lines by both online data and RT-PCR assay. Then, clinical assay revealed that high LINC00858 expression was significantly associated with advanced clinical progression and poor prognosis. Multivariate analysis demonstrated that high LINC00858 expression was an independent poor prognostic factor for CRC patients. Moreover, lost-of-function assay indicated that knockdown of LINC00858 suppressed CRC cells proliferation, migration and invasion, and promoted apoptosis. Mechanistically, bioinformatics analysis, dual-luciferase reporter assays, and western blot assays showed that LINC00858 functioned as competing endogenous RNA to repress miR-22-3p, which controlled its down-stream target YWHAZ. Then, we suggested that LINC00858 exerted its function through the miR-22-3p/YWHAZ axis. To our knowledge, this is the first report which showed the role of LINC00858 in the progression of CRC. Our findings indicated that LINC00858 played an important role in CRC, and may serve as a novel prognostic factor and therapeutic target.
机译:尽管长的非编码RNA LINC00858(LINC00858)已被证明与其他组织的肿瘤有关,但其与结直肠癌(CRC)的关系仍是未知的。我们旨在研究LINC00858在人类CRC中的表达及其机制。在这项研究中,我们首先发现通过在线数据和RT-PCR分析,在CRC组织和细胞系中LINC00858的表达均显着上调。然后,临床测定表明,LINC00858的高表达与晚期临床进展和不良预后显着相关。多变量分析表明,LINC00858高表达是CRC患者的独立不良预后因素。此外,功能丧失试验表明,敲低LINC00858可抑制CRC细胞的增殖,迁移和侵袭,并促进细胞凋亡。从机理上讲,生物信息学分析,双荧光素酶报告基因分析和蛋白质印迹分析表明,LINC00858充当竞争性内源RNA来抑制miR-22-3p,后者控制着其下游靶点YWHAZ。然后,我们建议LINC00858通过miR-22-3p / YWHAZ轴发挥其功能。据我们所知,这是第一份显示LINC00858在CRC进展中的作用的报告。我们的发现表明,LINC00858在CRC中起着重要作用,并且可能作为一种新的预后因素和治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号